Akili Investor Relations Material
Latest events
Q3 2023
Akili
Q1 2024
14 May, 2024
Q4 2023
29 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Akili Inc
Access all reports
Akili Inc. develops digital therapeutics and cognitive treatment technologies delivered through interactive software applications. Its solutions are designed to address cognitive impairments in neurological and psychiatric conditions. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
AKLI
Country
🇺🇸 United States